Literature DB >> 4404808

The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease.

N Svedmyr, R Malmberg, G Thiringer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4404808

Source DB:  PubMed          Journal:  Scand J Respir Dis        ISSN: 0036-5572


× No keyword cloud information.
  11 in total

1.  Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.

Authors:  G E Marlin; B J Hartnett; N Berend
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

Review 2.  Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

3.  Sympathomimetic bronchodilators: increased selectivity with lung-specific prodrugs.

Authors:  L A Svensson
Journal:  Pharm Res       Date:  1985-07       Impact factor: 4.200

4.  Intravenous treatment with rimiterol and salbutamol in asthma.

Authors:  G E Marlin; P Turner
Journal:  Br Med J       Date:  1975-06-28

5.  Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.

Authors:  G E Marlin; B J Hartnett; N Berend; N B Hacket
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

6.  The acute effects of the administration of rimiterol aerosol in asthmatic children.

Authors:  M I Blackhall; B Macartney; S R O'Donnell
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

7.  Investigation into isoprenaline resistance in patients with obstructive lung disease.

Authors:  A Lichterfeld; H Löllgen
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

8.  Dose-titration comparison of inhaled salbutamol and oral theophylline in asthma.

Authors:  G E Marlin; M R Harris; J A Klumpp; J Rutland
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

9.  Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.

Authors:  G E Marlin; P Turner
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

10.  Response to rimiterol and salbutamol aerosols administered by intermittent positive-pressure ventilation.

Authors:  N J Cooke; J A Kerr; R F Willey; M V Hoare; I W Grant; G K Cromptom
Journal:  Br Med J       Date:  1974-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.